Kurt Marshall Email & Phone Number

Denver, Co, Us

Denver, Co, Us

Lakewood, Colorado, Us

• Support pre- and post-sale activities for TerumoBCT’s CTT portfolio encompassing cell expansion through fill and finish.• Collaborate with medical affairs for ideation and data generation on novel applications of TerumoBCT technologies.• Train internal and external teams on TerumoBCT CTT products and assist with the generation of training tools.• Lead internal teams focused on the application of the Quantum Flex Bioreactor to clinically and commercially relevant cell types.

Boulder, Colorado, Us

• Built, led, and managed the Global Application Scientist team, to facilitate customer adoption of a multiplexed, microarray-based immunoassay instrument and consumables.• Identified, tracked, and interpreted performance metrics to drive continuous product, team, and support improvement.• Supported the entire product lifecycle, from conceptualization to launch and ongoing support.• Utilized proactive market analysis techniques, including VOC and competitive analysis, to identify and capitalize on strategic market opportunities and implement product improvements.• Collaborated closely with the Research and Development department to set product specifications and drive innovation, resulting in the successful launch of novel products.• Worked hand-in-hand with the Marketing team to develop compelling marketing tools and collateral that effectively communicated the value of our products to customers.

Boulder, Colorado, Us

Boulder, Colorado, Us

Boulder, Colorado, Us

• Led and directly managed the immune cell team (four scientists) performing complex CRISPR/Cas genome engineering in primary human immune cells to develop and characterize novel CAR-T cell therapies. • Planned, managed, and executed multiple cross-functional and cross-site projects with aggressive timelines in a start-up environment to develop novel CAR-T products and gene editing technologies.• Led and participated in the development, implementation, and optimization of novel methods and assays in support of next generation CAR-T products.• Led design and testing of cell therapy products and drove strategy for pre-clinical pipeline.

Basel, Baselstadt, Ch

• Site closure announced March 2021.• Lead analytical programs for the Colorado Process Development team. • Subject matter expert for analytical testing of process development derived AAV samples.• On-boarded new methods as well as adapted legacy methods for process development studies.• Collaborated across departments to implement updated processes and programs.

Cambridge, Cambridgeshire, Gb

• Led and collaborated on multiple projects in a matrixed environment focused on novel applications of gene editing and base editing including launching new lentiviral gene editing and synthetic guide RNA products with a focus on primary cell editing.• Designed, led, and performed both research and development stage experiments in support of life science tools in an ISO regulated environment including AAV, lentiviral, and non-viral (protein, mRNA, synthetic RNA/DNA) based products.• Transferred new methods and products to manufacturing. • Prepared customer facing documents in support of products and applications.

Cambridge, Cambridgeshire, Gb

Cambridge, Cambridgeshire, Gb

• Provided pre- and post-sales support for the combined Dharmacon and Horizon Discovery product portfolio including gene modulation products (CRISPR Cas9, CRISPRa, RNAi, cDNA/ORFs), custom oligonucleotide synthesis, engineered cell lines, and diagnostics. • Provided technical expertise and experimental design solutions to customers, sales representatives, and authorized distributors.• Authored customer-facing literature, performed document review, and acted as the voice of the customer for new product launches.• Acted as inside sales contact and project manager for custom oligonucleotide synthesis.

Chicago, Us

• Site became Horizon Discovery in September 2017.

Columbia, Mo, Us

• Managed and participated in multiple projects focused on vascular remodeling utilizing both animal and cell culture models.• Developed an ex vivo model for the study of abdominal aortic aneurysm.• Supervised and mentored a Ph.D. candidate studying proteolytic cleavage of the insulin receptorusing an in vitro system.• Participated in the development of grants for submission and the review of journal articles.

Columbia, Mo, Us

• Identified a novel modulator of both oxidative stress induced cell death and mitochondrial morphology.• Isolated, cultured and performed experiments on multiple primary and immortal cell lines.• Cloned and characterized adenoviruses and fusion proteins.• Generated, characterized and experimentally manipulated a cardiac specific inducible overexpression transgenic mouse model.

Thousand Oaks, Ca, Us

• Performed both cell and non-cell based assays (manual and automated) for drug potency qualification.• Managed samples and coordinated routine testing for Amgen’s global bioassay team using LIMS.• Cultured and maintained multiple non-adherent cell lines.• Maintained extensive records using an Electronic Laboratory Notebook.

Boulder, Colorado, Us

• Characterized the effects of aging in vitro using multiple cell lines.• Identified mechanisms of age-related arterial stiffening in vitro and in vivo.• Assisted with studies utilizing human subjects to study vascular function.

Foster City, Ca, Us

• Involved in the development of a cell based secondary drug-screening assay for small molecule therapeutics.

Doctor Of Philosophy (Ph.D.), Biomedical Sciences, General

Master'S Degree, Integrative Physiology

Bachelor'S Degree, Biology, General